| Target Price | $55.08 |
| Price | $47.39 |
| Potential | 16.23% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Baker Hughes 2026 . The average Baker Hughes target price is $55.08. This is 16.23% higher than the current stock price. The highest price target is $61.95 30.72% , the lowest is $40.40 14.75% . | |
| A rating was issued by 26 analysts: 21 Analysts recommend Baker Hughes to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Baker Hughes stock has an average upside potential 2026 of 16.23% . Most analysts recommend the Baker Hughes stock at Purchase. |
25 Analysts have issued a sales forecast Baker Hughes 2025 . The average Baker Hughes sales estimate is $27.7b . This is 0.18% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $29.0b 4.48% , the lowest is $26.6b 3.91% .
This results in the following potential growth metrics:
| 2024 | $27.8b | 9.11% |
|---|---|---|
| 2025 | $27.7b | 0.60% |
| 2026 | $28.5b | 3.17% |
| 2027 | $30.3b | 6.09% |
| 2028 | $31.0b | 2.54% |
| 2029 | $33.3b | 7.25% |
24 Analysts have issued an Baker Hughes EBITDA forecast 2025. The average Baker Hughes EBITDA estimate is $4.7b . This is 0.71% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.1b 7.44% , the lowest is $4.4b 7.88% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $4.6b | 22.04% |
|---|---|---|
| 2025 | $4.7b | 2.90% |
| 2026 | $5.1b | 8.81% |
| 2027 | $5.8b | 12.51% |
| 2028 | $6.1b | 4.95% |
| 2029 | $6.6b | 8.86% |
| 2024 | 16.50% | 11.85% |
|---|---|---|
| 2025 | 17.08% | 3.53% |
| 2026 | 18.01% | 5.44% |
| 2027 | 19.10% | 6.05% |
| 2028 | 19.55% | 2.36% |
| 2029 | 19.84% | 1.48% |
26 Baker Hughes Analysts have issued a net profit forecast 2025. The average Baker Hughes net profit estimate is $2.5b . This is 13.87% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.7b 8.32% , the lowest is $2.3b 18.78% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $3.0b | 53.32% |
|---|---|---|
| 2025 | $2.5b | 16.42% |
| 2026 | $2.6b | 6.40% |
| 2027 | $3.0b | 13.52% |
| 2028 | $3.5b | 14.90% |
| 2029 | $3.8b | 10.95% |
| 2024 | 10.70% | 40.52% |
|---|---|---|
| 2025 | 9.00% | 15.92% |
| 2026 | 9.28% | 3.11% |
| 2027 | 9.93% | 7.00% |
| 2028 | 11.13% | 12.08% |
| 2029 | 11.51% | 3.41% |
26 Analysts have issued a Baker Hughes forecast for earnings per share. The average Baker Hughes EPS is $2.53 . This is 12.76% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.69 7.24% , the lowest is $2.38 17.93% .
This results in the following potential growth metrics and future valuations:
| 2024 | $2.98 | 56.02% |
|---|---|---|
| 2025 | $2.53 | 15.10% |
| 2026 | $2.69 | 6.32% |
| 2027 | $3.05 | 13.38% |
| 2028 | $3.50 | 14.75% |
| 2029 | $3.89 | 11.14% |
| Current | 16.34 | 11.79% |
|---|---|---|
| 2025 | 18.77 | 14.86% |
| 2026 | 17.64 | 6.02% |
| 2027 | 15.54 | 11.90% |
| 2028 | 13.52 | 13.00% |
| 2029 | 12.19 | 9.84% |
Based on analysts' sales estimates for 2025, the Baker Hughes stock is valued at an EV/Sales of 1.77 and an P/S ratio of 1.69 .
This results in the following potential growth metrics and future valuations:
| Current | 1.76 | 8.64% |
|---|---|---|
| 2025 | 1.77 | 0.30% |
| 2026 | 1.71 | 3.08% |
| 2027 | 1.61 | 5.74% |
| 2028 | 1.57 | 2.48% |
| 2029 | 1.47 | 6.76% |
| Current | 1.69 | 12.70% |
|---|---|---|
| 2025 | 1.69 | 0.18% |
| 2026 | 1.64 | 3.08% |
| 2027 | 1.54 | 5.74% |
| 2028 | 1.51 | 2.48% |
| 2029 | 1.40 | 6.77% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 28 2025 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 27 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 27 2025 |
| Stifel |
Buy
➜
Buy
|
Unchanged | Oct 27 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 16 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 28 2025 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 27 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 27 2025 |
|
Unchanged
Stifel:
Buy
➜
Buy
|
Oct 27 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 16 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


